Cas 1613022-75-5,2-phenylthiazole-4-carboxylic acid (1-imidazo[1,2-a]pyrazin-8-yl-pyrrolidin-3-yl)-amide

1613022-75-5

Post Buying Request

Basic information

Product Name: 2-phenylthiazole-4-carboxylic acid (1-imidazo[1,2-a]pyrazin-8-yl-pyrrolidin-3-yl)-amide
Synonyms: 2-phenylthiazole-4-carboxylic acid (1-imidazo[1,2-a]pyrazin-8-yl-pyrrolidin-3-yl)-amide
CAS NO:1613022-75-5
Molecular Formula:
Molecular Weight: 390.469
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 2-phenylthiazole-4-carboxylic acid (1-imidazo[1,2-a]pyrazin-8-yl-pyrrolidin-3-yl)-amide(CAS DataBase Reference)
NIST Chemistry Reference: 2-phenylthiazole-4-carboxylic acid (1-imidazo[1,2-a]pyrazin-8-yl-pyrrolidin-3-yl)-amide(1613022-75-5)
EPA Substance Registry System: 2-phenylthiazole-4-carboxylic acid (1-imidazo[1,2-a]pyrazin-8-yl-pyrrolidin-3-yl)-amide(1613022-75-5)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1613022-75-5(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1613022-75-5 Suppliers

Recommended suppliers

1613022-75-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1613022-75-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,1,3,0,2 and 2 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1613022-75:
(9*1)+(8*6)+(7*1)+(6*3)+(5*0)+(4*2)+(3*2)+(2*7)+(1*5)=115
115 % 10 = 5
So 1613022-75-5 is a valid CAS Registry Number.

1613022-75-5Upstream product

1613022-75-5Downstream Products

1613022-94-8 C₂₀H₁₈N₆OS*C₂HF₃O₂

1613022-75-5Relevant academic research and scientific papers

CXCR7 ANTAGONISTS

-

, (2014/06/23)

Compounds having formula I, or pharmaceutically acceptable salts, hydrates or N-oxides thereof are provided and are useful for binding to CXCR7, and treating diseases that are dependent, at least in part, on CXCR7 activity. Accordingly, the present invention provides in further aspects, compositions containing one or more of the above-noted compounds in admixture with a pharmaceutically acceptable excipient.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1613022-75-5